Ascendis Pharma A/s (NASDAQ: ASND)
Ascendis Pharma A/s Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Ascendis Pharma A/s Company Info
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
News & Analysis
Valuation
Earnings Transcripts
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript
ASND earnings call for the period ending September 30, 2021.
Ascendis Pharma A/S (ASND) Q2 2021 Earnings Call Transcript
ASND earnings call for the period ending June 30, 2021.
Ascendis Pharma A/S (ASND) Q1 2021 Earnings Call Transcript
ASND earnings call for the period ending March 31, 2021.
Ascendis Pharma A/S (ASND) Q4 2020 Earnings Call Transcript
ASND earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.